Global Livestock Anti-infectives Market Size By Type (Injection, Unguent), By Application (Cattle, Equine), By Region, And Segment Forecasts, 2023 to 2032

The Global Livestock Anti-infectives Market was valued at USD 6.1 billion in 2023 and is projected to reach USD 9.3 billion by 2031, growing at a CAGR of 5.4% during the forecast period from 2023 to 2031. This growth is propelled by the increasing prevalence of infectious diseases in livestock, rising awareness regarding animal health and biosecurity, and the growing demand for high-quality animal-based products globally. The market includes a range of anti-infective solutions such as antibiotics, antivirals, antifungals, and antiparasitics administered to maintain livestock health and productivity.

As the global livestock sector continues to evolve, especially in developing regions with expanding meat and dairy industries, the demand for reliable disease management solutions is rising. Additionally, stringent food safety standards and government initiatives promoting livestock welfare are further fueling the market's momentum.

Drivers:

1. Rising Incidence of Livestock Infections:

The surge in zoonotic and non-zoonotic infections among livestock is significantly increasing the use of anti-infective agents to ensure animal well-being and reduce mortality rates.

2. Demand for Safe and Quality Animal Products:

With growing consumer awareness regarding food safety and sustainability, there is an increased focus on maintaining healthy livestock, driving the demand for anti-infective products.

3. Government Support and Veterinary Healthcare Advancements:

Supportive regulations, animal vaccination campaigns, and the availability of advanced veterinary healthcare facilities are key drivers stimulating the market.

Restraints:

1. Regulatory Restrictions on Antibiotic Use:

Several countries are imposing stricter regulations on the use of antibiotics in livestock, particularly growth-promoting antibiotics, which may challenge market growth.

2. Antimicrobial Resistance (AMR) Concerns:

The emergence of AMR due to excessive use of anti-infectives is a significant global concern that may lead to limited usage and encourage alternative solutions, affecting market dynamics.

Opportunity:

1. Rising Livestock Production in Emerging Economies:

Developing nations in Asia-Pacific, Latin America, and Africa are experiencing rapid livestock sector growth, presenting lucrative opportunities for anti-infective providers.

2. Innovation in Veterinary Pharmaceuticals:

Advancements in biotechnology and veterinary pharmaceuticals, including targeted drug delivery and novel formulations, are creating new avenues for growth in the livestock anti-infectives space.

Market by System Type Insights:

The Antibiotics segment dominated the global livestock anti-infectives market in 2023 due to its widespread application in treating bacterial infections across poultry, cattle, and swine. However, the Antiparasitics segment is expected to witness the fastest growth during the forecast period, driven by the increasing occurrence of parasitic infestations and the development of novel broad-spectrum antiparasitic agents.

Market by End-use Insights:

In terms of end use, the Poultry segment held the largest share of the market in 2023, accounting for over 35%. Poultry farming, being highly susceptible to infections due to intensive production practices, has driven the demand for effective anti-infective solutions. The Cattle segment is also projected to grow steadily owing to increasing dairy and beef consumption globally.

Market by Regional Insights:

Geographically, Asia-Pacific led the market in 2023 and is expected to maintain its dominance through 2031. The region’s large livestock population, coupled with rising meat consumption and government investments in animal healthcare, is a key contributor to growth. North America and Europe also hold substantial shares due to their advanced veterinary infrastructure and stringent food safety regulations.

Competitive Scenario:

Key players operating in the Global Livestock Anti-infectives Market include:

Zoetis Inc.

Elanco Animal Health

Merck Animal Health

Boehringer Ingelheim

Ceva Santé Animale

Virbac

Phibro Animal Health Corporation

Vetoquinol S.A.

Bayer Animal Health

Huvepharma

These companies are focusing on strategic collaborations, R&D investment, and portfolio expansion to strengthen their market positions.

Recent Developments:

In 2023, Zoetis launched a next-generation antiparasitic for multi-species livestock treatment with enhanced safety profiles.

In 2024, Elanco partnered with a biotechnology firm to develop antibiotic alternatives targeting gut health and immune modulation.

In 2025, Merck announced the global rollout of a vaccine-integrated antimicrobial strategy to reduce AMR risks.

Scope of Work – Global Livestock Anti-infectives Market

Report Metric Details

Market Size (2023) USD 6.1 billion

Projected Market Size (2031) USD 9.3 billion

CAGR (2023-2031) 5.4%

Market Segments By System Type (Antibiotics, Antivirals, Antiparasitics, Antifungals); By End-use (Poultry, Cattle, Swine, Others)

Growth Drivers Rising livestock diseases, growing demand for quality animal products, supportive animal health initiatives

Opportunities Innovation in veterinary pharma, growth in emerging livestock economies

FAQs:

1) What is the current market size of the Global Livestock Anti-infectives Market?

The market was valued at USD 6.1 billion in 2023.

2) What is the major growth driver of the Global Livestock Anti-infectives Market?

The key growth driver is the rising incidence of infectious diseases among livestock and the demand for safe, high-quality animal products.

3) Which is the largest region during the forecast period in the Global Livestock Anti-infectives Market?

Asia-Pacific is expected to dominate the market during the forecast period.

4) Which segment accounted for the largest market share in the Global Livestock Anti-infectives Market?

The Antibiotics segment accounted for the largest share in 2023.

5) Who are the key market players in the Global Livestock Anti-infectives Market?

Key players include Zoetis, Elanco, Merck Animal Health, Boehringer Ingelheim, Ceva, Virbac, and others.